Coverage
Filings
Genmab A/S announced encouraging results from its Phase 1/2 RAINFOL-01 trial for rinatabart sesutecan (Rina-S), an investigational antibody-drug conjugate (ADC), in heavily pretreated patients with advanced endometrial cancer.
| 15 Oct 2007 |
| Genmab Amends HuMax-CD4 Pivotal Study in CTCL | 11 Oct 2007 |
| Grant of Warrants in Genmab A/S | 4 Oct 2007 |
| Roche Files CTA for Third Genmab Antibody | 2 Oct 2007 |
| Genmab to Attend Two October Investor Conferences | 1 Oct 2007 |